Bioactivation of diclofenac in human hepatocytes and the proposed human hepatic proteins modified by reactive metabolites

References

• Arcaro A, Daga M, Cetrangolo GP, et al. (2015). Generation of adducts of 4-hydroxy-2-nonenal with heat shock 60 kDa protein 1 in human promyelocytic HL-60 and monocytic THP-1 cell lines. Oxid Med Cell Longev 2015:1–14.
   Web of Science ®Google Scholar
• Benet LZ, Spahn-Langguth H, Iwakawa S, et al. (1993). Predictability of the covalent binding of acidic drugs in man. Life Sci 53:141–6.
   PubMed Web of Science ®Google Scholar
• Boelsterli UA, Lim P. (2007). Mitochondrial abnormalities—a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol 220:92–107.
   PubMed Web of Science ®Google Scholar
• Chipinda I, Hettick JM, Siegel PD. (2011). Haptenation: Chemical reactivity and protein binding. J Allergy 2011:1–12.
   Google Scholar
• Dambach DM, Misner D, Brock M, et al. (2016). Safety lead optimization and candidate identification: integrating new technologies into decision-making. Chem Res Toxicol 29:452–72.
   PubMed Web of Science ®Google Scholar
• Darnell M, Breitholtz K, Isin EM, et al. (2015). Significantly different covalent binding of oxidative metabolites, acyl glucuronides, and S-acyl CoA conjugates formed from xenobiotic carboxylic acids in human liver microsomes. Chem Res Toxicol 28:886–96.
   PubMed Web of Science ®Google Scholar
• Day SH, Mao A, White R, et al. (2005). A semi-automated method for measuring the potential for protein covalent binding in drug discovery. J Pharmacol Toxicol Methods 52:278–85.
   PubMedGoogle Scholar
• den Braver MW, den Braver-Sewradj SP, Vermeulen NPE, Commandeur JNM. (2016). Characterization of cytochrome P450 isoforms involved in sequential two-step bioactivation of diclofenac to reactive p-benzoquinone imines. Toxicol Lett 253:46–54.
   PubMed Web of Science ®Google Scholar
• Ding A, Ojingwa JC, McDonagh AF, et al. (1993). Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc Natl Acad Sci U S A 90:3797–801.
   PubMed Web of Science ®Google Scholar
• Ding A, Zia-Amirhosseini P, Mcdonagh AF, et al. (1995). Reactivity of tolmetin glucuronide with human serum albumin identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab Dispos 23:369–76.
   PubMed Web of Science ®Google Scholar
• Galkin A, Kulakova L, Melamud E, et al. (2007). Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite. Giardia lamblia J Biol Chem 282:4859–67.
   PubMed Web of Science ®Google Scholar
• Gan J, Harper TW, Hsueh M-M, et al. (2005). Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites. Chem Res Toxicol 18:896–903.
   PubMed Web of Science ®Google Scholar
• Gan J, Zhang H, Humphreys WG. (2016). Drug − protein adducts: chemistry, mechanisms of toxicity, and methods of characterization. Chem Res Toxicol 29:2040–57.
   PubMed Web of Science ®Google Scholar
• Goda K, Takahashi T, Kobayashi A, et al. (2016). Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury. J Toxicol Sci 41:605–15.
   PubMed Web of Science ®Google Scholar
• Golizeh M, Geib T, Sleno L. (2016). Identification of 4-hydroxynonenal protein targets in rat, mouse and human liver microsomes by two-dimensional liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 30:1488–94.
   PubMedGoogle Scholar
• Greaves P, Williams A, Eve M. (2004). First dose of potential new medicines to humans: How animals help. Nat Rev Drug Discov 3:226–36.
   PubMed Web of Science ®Google Scholar
• Hammond TG, Meng X, Jenkins RE, et al. (2014). Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients. J Pharmacol Exp Ther 350:387–402.
   PubMed Web of Science ®Google Scholar
• Hargus SJ, Martin BM, George JW, Pohl LR. (1995). Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac. Chem Res Toxicol 8:993–6.
   PubMed Web of Science ®Google Scholar
• Inoue K, Shibata Y, Takahashi H, et al. (2009). A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide. Drug Metab Pharmacokinet 24:245–54.
   PubMed Web of Science ®Google Scholar
• Isbell MA, Morin DM, Boland B, et al. (2005). Identification of proteins adducted by reactive naphthalene metabolites in vitro. Proteomics 5:4197–204.
   PubMed Web of Science ®Google Scholar
• Jinno N, Tagashira M, Tsurui K, Yamada S. (2014). Contribution of cytochrome P450 and UDT-glucuronosyltransferase to the metabolism of drugs containing carboxylic acid groups: risk assessment of acylglucuronides using human hepatocytes. Xenobiotica 44:677–86.
   PubMed Web of Science ®Google Scholar
• King C, Tang W, Ngui J, et al. (2001). Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61:49–53.
   PubMed Web of Science ®Google Scholar
• Koen YM, Hanzlik RP. (2002). Identification of seven proteins in the endoplasmic reticulum as targets for reactive metabolites of bromobenzene. Chem Res Toxicol 15:699–706.
   PubMed Web of Science ®Google Scholar
• Kola I, Landis J. (2004). Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711–5.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Hartley D, et al. (1999). Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther 289:580–6.
   PubMed Web of Science ®Google Scholar
• Meng X, Howarth A, Earnshaw CJ, et al. (2013). Detection of drug bioactivation in vivo: mechanism of nevirapine − albumin conjugate formation in patients. Chem Res Toxicol 26:575–83.
   PubMed Web of Science ®Google Scholar
• Miyamoto G, Zahid N, Uetrecht JP. (1997). Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem Res Toxicol 10:414–9.
   PubMed Web of Science ®Google Scholar
• Nagayama S, Yokoi T, Kawaguchi Y, Kamataki T. (1994). Occurrence of autoantibody to protein disulfide isomerase in rats with xenobiotic-induced hepatitis. J Toxicol Sci 19:155–61.
   PubMedGoogle Scholar
• Noort D, Zuylen A, Fidder A, et al. (2008). Protein adduct formation by glucuronide metabolites of permethrin. Chem Res Toxicol 21:1396–406.
   PubMed Web of Science ®Google Scholar
• Pham NT, Jewell WT, Morin D, Buckpitt AR. (2012). Analysis of naphthalene adduct binding sites in model proteins by tandem mass spectrometry. Chem Biol Interact 199:120–8.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Duan L, Akakpo JY, Jaeschke H. (2018). Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives. J. Clin Trans Res 4:75–100.
   Google Scholar
• Ramm S, Limbeck E, Mally A. (2016). Functional and cellular consequences of covalent target protein modification by furan in rat liver. Toxicology 361–362:49–61.
   PubMed Web of Science ®Google Scholar
• Sallustio BC, DeGraaf YC, Weekley JS, Burcham PC. (2006). Bioactivation of carboxylic acid compounds by UDP-glucuronosyltransferases to DNA-damaging intermediates: role of glycoxidation and oxidative stress in genotoxicity. Chem Res Toxicol 19:683–91.
   PubMed Web of Science ®Google Scholar
• Takakusa H, Masumoto H, Makino C, et al. (2009). Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione. Drug Metab Pharmacokinet 24:100–7.
   PubMed Web of Science ®Google Scholar
• Tang W, Stearns RA, Bandiera SM, et al. (1999a). Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites. Drug Metab Dispos 27:365–72.
   PubMed Web of Science ®Google Scholar
• Tang W, Stearns RA, Wang RW, et al. (1999b). Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem Res Toxicol 12:192–9.
   PubMed Web of Science ®Google Scholar
• Thompson RA, Isin EM, Li Y, et al. (2011). Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development. Chem Biol Interact 192:65–71.
   PubMed Web of Science ®Google Scholar
• Thompson RA, Isin EM, Li Y, et al. (2012). In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem Res Toxicol 25:1616–32.
   PubMed Web of Science ®Google Scholar
• Tolson JK, Dix DJ, Voellmy RW, Roberts SM. (2006). Increased hepatotoxicity of acetaminophen in Hsp70i knockout mice. Toxicol Appl Pharmacol 210:157–62.
   PubMed Web of Science ®Google Scholar
• Uetrecht J, Naisbitt JD. (2013). Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev 65:779–808.
   PubMed Web of Science ®Google Scholar